Stocks/APTV

APTV three-lens brief

Evidence-based stock research on APTV. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of 07:00 ET
$39.05$39.41$88.93

Performance

1W
-8.9%
1M
-9.5%
3M
-19.8%
6M
-28.3%
YTD
-48.2%
1Y
-52.4%
3Y
—
5Y
—
APTV · Nightly brief
Inspect

50-day MA below 200-day MA (death-cross regime); price below both. · Trading at 1% of its 52-week range — deep in the lower band.

  • Trading at 1% of its 52-week range — deep in the lower band.
  • 50-day MA below 200-day MA (death-cross regime); price below both.
  • Underperforming SPY by 8.0pp over 30 days.
  • P/E of 11.0 — trading at a value multiple.
  • Analyst mean target $58.61 — 49% above current (18 analysts).

APTV closed at $39.41 (-0.40%) as of 2026-11-12. Market cap: $7.98B. P/E (trailing) 11.0. Price is below the 50-day MA and below the 200-day MA. Positives: p/E of 11.0 — trading at a value multiple.; analyst mean target $58.61 — 49% above current (18 analysts).. Concerns: trading at 1% of its 52-week range — deep in the lower band.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $3.20B, net income $194.00M, free cash flow $1.55B.

Market ✓· Fundamentals ✓· 1 events
Informational only · Not investment advice
Three-lens method

Why three lenses on APTV, not one.

A single reasoning model has blind spots it doesn’t know about. We examine APTV across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://www.clearpathinvest.app/embed/APTV"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath APTV brief"></iframe>